US health authority reprimands large pharmaceutical firms after disagreement on drug discounts
Earlier in the week, the US HRSA sent a letter to many of the largest companies in the pharmaceutical industry concerning their approach to the 340B program which aims to ensure that hospitals get drug discounts.
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY NIELSINE NIELSEN
The US Department of Health & Human Services (HHS) is cracking down on many of the largest players in the pharmaceutical industry according to healthcare media Endpoints.
Expres2ion CEO Bent U. Frandsen is one of 3,000 volunteers participating in a phase III trial of Bavarian Nordic’s Covid-19 booster candidate. If the vaccine reaches the market, Expres2ion will be entitled to royalties.